The Journal of Heart and Lung Transplantation
Volume 27, Issue 4 , Pages 457-461 , April 2008

Clenbuterol Increases Lean Muscle Mass but Not Endurance in Patients With Chronic Heart Failure

  • Gayathri Kamalakkannan, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Christopher M. Petrilli, BS

      Affiliations

    • Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
    • ,
  • Isaac George, MD

      Affiliations

    • Division of Cardiothoracic Surgery, Department of Surgery, Columbia College of Physicians and Surgeons, New York, New York
    • ,
  • John LaManca, PhD

      Affiliations

    • Department of Health, Physical Education & Human Performance, Salisbury University, Salisbury, Maryland.
    • ,
  • Brooke T. McLaughlin, MPH

      Affiliations

    • Division of Cardiology, Columbia College of Physicians and Surgeons, New York, New York
    • ,
  • Elizabeth Shane, MD

      Affiliations

    • Division of Endocrinology, Department of Medicine, Columbia College of Physicians and Surgeons, New York, New York
    • ,
  • Donna M. Mancini, MD

      Affiliations

    • Division of Cardiology, Columbia College of Physicians and Surgeons, New York, New York
    • ,
  • Simon Maybaum, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
    • Corresponding Author InformationReprint requests: Simon Maybaum, MD, Center for Advanced Cardiac Therapy, Montefiore Medical Center, 3400 Bainbridge Ave, 7th Floor, Bronx, New York 10467. Telephone: 718-920-2626. Fax: 718-652-1822.

Received 19 October 2007 ,Revised 10 January 2008 ,Accepted 12 January 2008.

References 

  1. Gibbs JSR, Keegan J, Wright C, Fox KM, Poole-Wilson PA. Pulmonary artery changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol. 1990;15:52–61
  2. Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol. 1984;53:1308–1315
  3. Savin WM, Haskell WL, Schroeder JS, Stinson EB. Cardiopulmonary responses of cardiac transplant to graded symptom limited exercise. Circulation. 1980;62:55–60
  4. Sullivan MJ, Green HG, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81:518–527
  5. Massie B, Conway M, Yonge R, et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation. 1987;76:1009–1019
  6. Lipkin DP, Jones DA, Round JM, Poole-Wilson PA. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol. 1988;18:187–195
  7. Chua TP, Anker SD, Harrington D, Coats AJS. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br Heart J. 1995;74:381–385
  8. Opasich C, Ambrosino N, Felicetti G, et al. Heart failure related myopathy (Clinical and pathophysiological insights). Eur Heart J. 1999;20:1191–1200
  9. Magnusson G, Gordon A, Kaijser L, et al. High intensity knee extensor training, in patients with chronic heart failure (Major skeletal muscle improvement). Eur Heart J. 1996;17:1048–1055
  10. Martineau L, Horan M, Rothwell NJ, Little RA. Salbutamol a b2-adrenoreceptor agonist, increases skeletal muscle strength in young men. Clin Sci. 1992;83:615–621
  11. Di Gioacchino M, Mezzetti A, Mancini M, et al. Study of the cardiovascular effects of clenbuterol in exercise-induced asthma. Respiration. 1987;51:205–213
  12. Pasotti C, Capra A, Vibelli C. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. Int J Clin Pharmacol Biopharm. 1979;17:176–180
  13. Pasotti C, Gandolfi P, Vibelli C. Cardiovascular responses in normal man to beta adrenergic stimulation with clenbuterol (NAB 365). Curr Ther Res. 1980;28:235
  14. Beckett AH. Clenbuterol and sport. [letter] Lancet. 1992;340:1165
  15. Perry H. Clenbuterol: a medal in tablet form?. [letter] Br J Sp Med. 1993;27:141
  16. Maltin CA, Delday MI, Watson JS, et al. Clenbuterol, a beta-adrenoreceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci. 1993;84:651–654
  17. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873–1884
  18. George I, Xydas S, Mancini DM, et al. Effect of CLEN on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant. 2006;25:1084–1090
  19. Warren MP, Constantini NE. Sports endocrinology. Totowa, NJ: Humana Press; 2000;
  20. Devereux R, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613–618
  21. Rector TS, Kubo SH, Cohn JN. Patients’ self-assessment of their congestive heart failure (Part 2: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire). Heart Fail. 1987;198–209
  22. Harridge SD, Magnusson G, Gordon A. Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. Eur Heart J. 1996;17:896–901
  23. Gosker HR, Wouters EFM, Can Der Vusse GJ, Schols AMWJ. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000;71:1033–1047
  24. Hayes A. Williams DA (Contractile properties of clenbuterol-treated mdx muscle are enhanced by low-intensity swimming). J Appl Physiol. 1997;82:435–439
  25. Petrou M, Clarke S, Morrison K, Bowles C, Dunn M, Yacoub MH. CLEN increases stroke power and contractile speed of skeletal muscle for cardiac assist. Circulation. 1999;99:713–720

 This work was supported in part through a grant from the Foundation for the Advancement of Cardiac Therapies (FACT) Jupiter, Florida, and from Parent Project Muscular Dystrophy (PPMD), Middletown, Ohio.

 Dr Maybaum is listed as coinventor on a patent held by Columbia University for the use of clenbuterol to improve cardiac and skeletal muscle function in patients with congestive heart failure.

PII: S1053-2498(08)00041-7

doi: 10.1016/j.healun.2008.01.013

The Journal of Heart and Lung Transplantation
Volume 27, Issue 4 , Pages 457-461 , April 2008

Article Tools

* Image Usage & Resolution